Facts on DCTH's PHP System

Positive trial results, market advantages and platform technology.

By Wall Street Media on MSN Money Jun 10, 2010 6:37PM

Written by Douglas Estadt

 

Wall Street Media presents exclusive video of the internationally renowned Interventional Radiologist and Delcath’s Chief Medical Officer, Dr. Krishna Kandarpa, MD, Ph.D.  Dr. Kandarpa discusses PHP’s extremely positive trial results and market advantages and potential.  He also clarifies recent inaccuracies concerning PHP in the media.

 

  • There are no requirements under Delcath’s SPA for enrollment minimums for either ocular or cutaneous melanoma
  • Overall survival used only 20% of the time (2005-2007); progression free used 80% of the time
  • Clinic breakdown populations are immaterial as there was no difference in response in patients with either ocular and cutaneous melanoma
  • The market for this system will be far larger than some figures currently being inaccurately presented in the media: 80% of liver cancer cases are in Asia so those presenting figures for only cases in America are either somehow ignorant of this crucial fact, or behaving disingenuously
  • The study was designed so that patients were allowed to crossover from the Best Alternative Care group to the PHP group and 27 patients were saved due to this humanitarian aspect of the trial

To hear more about DCTH, view the video below.

Visit Wall Street Media. We feature exclusive insights from the world's leading transparent investors.
0Comments

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

STOCK SCOUTER

StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

116
116 rated 1
265
265 rated 2
429
429 rated 3
612
612 rated 4
499
499 rated 5
525
525 rated 6
701
701 rated 7
533
533 rated 8
337
337 rated 9
131
131 rated 10
12345678910

Top Picks

SYMBOLNAMERATING
UPLULTRA PETROLEUM Corp10
COPCONOCOPHILLIPS9
TAT&T Inc9
DVNDEVON ENERGY CORPORATION9
EOGEOG RESOURCES Inc9
More

VIDEO ON MSN MONEY

ABOUT

Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.